Andreas Due Ørskov

938 total citations
19 papers, 561 citations indexed

About

Andreas Due Ørskov is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Andreas Due Ørskov has authored 19 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Andreas Due Ørskov's work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (5 papers) and Epigenetics and DNA Methylation (5 papers). Andreas Due Ørskov is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (5 papers) and Epigenetics and DNA Methylation (5 papers). Andreas Due Ørskov collaborates with scholars based in Denmark, United States and Sweden. Andreas Due Ørskov's co-authors include Kirsten Grønbæk, Peter A. Jones, Minmin Liu, Marianne Bach Treppendahl, Mette Skov Holm, Lone S. Friis, Anni Skovbo, Marianne Hokland, Hitoshi Ohtani and Linn Gillberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Andreas Due Ørskov

15 papers receiving 553 citations

Peers

Andreas Due Ørskov

HEMAT

IMMUN

ONCOL

Masakazu Sawanobori Japan

Lorenzo Iovino United States

M. Fátima Macedo Portugal

Supinya Iamsawat United States

Guifang Ouyang China

Shan Meng China

Juan C. Ravell United States

Lijia Yang China

Julie Turzanski United Kingdom

Peggy Schwarz Germany

Masakazu Sawanobori Japan

Andreas Due Ørskov

97 ×0.4

166 ×0.7

HEMAT

80 ×0.6

IMMUN

49 ×0.5

46 ×0.5

ONCOL

Citations per year, relative to Andreas Due Ørskov Andreas Due Ørskov (= 1×) peers Masakazu Sawanobori

Countries citing papers authored by Andreas Due Ørskov

Since Specialization

Citations

This map shows the geographic impact of Andreas Due Ørskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Due Ørskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Due Ørskov more than expected).

Fields of papers citing papers by Andreas Due Ørskov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Due Ørskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Due Ørskov. The network helps show where Andreas Due Ørskov may publish in the future.

Co-authorship network of co-authors of Andreas Due Ørskov

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Due Ørskov. A scholar is included among the top collaborators of Andreas Due Ørskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Due Ørskov. Andreas Due Ørskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Tulstrup, Morten, Jakob Werner Hansen, Claudia Schöllkopf, et al.. (2025). Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations. Haematologica. 110(5). 1164–1169. 1 indexed citations

Jensen, Jonas, Joachim Bæch, Claus Werenberg Marcher, et al.. (2025). Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline‐containing chemotherapy: A population‐based matched cohort study. British Journal of Haematology. 207(4). 1416–1424.

Jensen, Jonas, Claudia Schöllkopf, Nina Toft, et al.. (2025). Reproductive patterns and birth rates in acute leukaemia survivors: A Danish population‐based cohort study. British Journal of Haematology. 207(4). 1435–1444.

Fonager, Kirsten, Ingolf Mølle, Andreas Due Ørskov, et al.. (2024). Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study. Clinical Epidemiology. Volume 16. 191–202. 2 indexed citations

Toft, Nina, et al.. (2024). Temporal changes in survival among adult patients with acute lymphoblastic leukaemia diagnosed in the period 1998-2020 – A Danish nationwide population-based cohort study. European Journal of Cancer. 212. 114338–114338. 2 indexed citations

Roug, Anne Stidsholt, Claus Werenberg Marcher, Andreas Due Ørskov, et al.. (2024). Outcomes among non‐Western immigrant patients and Danish‐born patients with acute myeloid Leukaemia: A Danish population‐based cohort study. British Journal of Haematology. 208(2). 564–569.

Brøndum, Rasmus Froberg, Andreas Due Ørskov, Claus Werenberg Marcher, et al.. (2023). Venetoclax‐based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy. European Journal Of Haematology. 111(4). 573–582. 3 indexed citations

Gillberg, Linn, Stine Ulrik Mikkelsen, Andreas Due Ørskov, et al.. (2023). LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome. Clinical Epigenetics. 15(1). 91–91.

Tulstrup, Morten, Andreas Due Ørskov, Claus Werenberg Marcher, et al.. (2023). Overall Survival in Patients with Ccus Depends on Presence of Anemia. Blood. 142(Supplement 1). 1864–1864. 1 indexed citations

10.

Hansen, Jakob Werner, Andreas Due Ørskov, Konstantinos Dimopoulos, et al.. (2022). Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes. HemaSphere. 6(5). e0713–e0713. 11 indexed citations

11.

Ohtani, Hitoshi, Andreas Due Ørskov, Linn Gillberg, et al.. (2020). Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-Azacytidine. Cancer Research. 80(12). 2441–2450. 36 indexed citations

12.

Gillberg, Linn, Andreas Due Ørskov, Ammar Nasif, et al.. (2019). Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes. Clinical Epigenetics. 11(1). 143–143. 58 indexed citations

13.

Ørskov, Andreas Due, Sunil Kumar Saini, Anne-Mette Bjerregaard, et al.. (2017). Activation of T Cells Specific to Endogenous Retroviral Peptides: Possible Association with Clinical Response to Azacitidine in Myeloid Malignancies. Blood. 130. 4243–4243. 1 indexed citations

14.

Ørskov, Andreas Due & Kirsten Grønbæk. (2017). DNA Methyltransferase Inhibitors in Myeloid Cancer. The Cancer Journal. 23(5). 277–285. 4 indexed citations

15.

Gillberg, Linn, Andreas Due Ørskov, Minmin Liu, et al.. (2017). Vitamin C – A new player in regulation of the cancer epigenome. Seminars in Cancer Biology. 51. 59–67. 70 indexed citations

16.

Liu, Minmin, Hitoshi Ohtani, Wanding Zhou, et al.. (2016). Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine. Proceedings of the National Academy of Sciences. 113(37). 10238–10244. 150 indexed citations

17.

Hansen, Jakob Werner, Maj Westman, Lene Dissing Sjø, et al.. (2016). Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes. American Journal of Hematology. 91(12). 1234–1238. 28 indexed citations

18.

Glenthøj, Andreas, et al.. (2016). Immune Mechanisms in Myelodysplastic Syndrome. International Journal of Molecular Sciences. 17(6). 944–944. 44 indexed citations

19.

Ørskov, Andreas Due, Marianne Bach Treppendahl, Anni Skovbo, et al.. (2015). Hypomethylation and up-regulation ofPD-1in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation. Oncotarget. 6(11). 9612–9626. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact